Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SUVOREXANT
- Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
- Insomnia Treatment and EMA (Ecological Momentary Assessment) Outcomes
- Measuring Acute Drug Demand in Humans
- Efficacy of Suvorexant on Post-operative Sleep Disturbance
- REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant
- The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder
- Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder
- Orexin's Role in The Neurobiology of Substance Use Disorder
- Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes
- Trial of Suvorexant for Sleep in Children With Autism
- Suvorexant for Opioid/Stimulant Co-use
- Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep
- Lemborexant Shift Work Treatment Study
- Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
- A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem
- An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia
- Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia
- Sleep Trial to Prevent Alzheimer's Disease
- Efficacy and Safety of Suvorexant (MK-4305) for Reducing Incidence of Delirium in Japanese Participants at High Risk of Delirium (MK-4305-085)
- Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder
- A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study
- Dual-Orexin Antagonism as a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder
- Suvorexant to Reduce Symptoms of Nicotine Use
- Medication Development in Alcoholism: Suvorexant Versus Placebo
- Suvorexant and Sleep/Delirium in ICU Patients
- Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)
- Targeting Orexin to Treat Nicotine Dependence
- Suvorexant and Cocaine
- Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence
- Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes
- Medical Management of Sleep Disturbance During Opioid Tapering
- Impact of Suvorexant on Sympathetic Nerve Activity and Baroreflex Function in Chronic Insomnia
- Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia
- Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant
- Exogenous Melatonin in Intensive Care Unit Chronodisruption
- Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users
- Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- The Efficacy of Suvorexant in Treatment of Patients With Substance Use Disorder and Insomnia: A Pilot Open Trial
- A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users
- A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia
- Sleep Quality and Amyloid-Beta Kinetics
- Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia
- Suvorexant and Sleep's Benefits to Therapeutic Exposure for Posttraumatic Stress Disorder
- To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia
- Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use
- Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)
- A Pilot Study of Suvorexant for Insomnia in Parkinson Disease
- Suvorexant and Trauma Related Insomnia
- Suvorexant in Insomnia Co-morbid With Fibromyalgia
- A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia
- The Role of Orexin in Human Panic Disorder
- Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder
- Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers
- Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036)
- Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)
- Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)
- Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)
- Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)
- Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)
- A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)
- Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)
Clinical trials list
click for details